Visibly’s at-home tests take six minutes to complete and can be self-administered on a computer or mobile device.
The vision test results are sent to an eye-care specialist immediately, who can then make patient recommendations.
“After many years working with the FDA, we are excited to receive this clearance,” Brent Rasmussen, CEO of Visibly, said in the release. “We look forward to fulfilling our mission of bringing affordable, accessible vision care to the masses.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.